FDAnews Drug Daily Bulletin

ADVANCIS PHARMA STILL EXPECTS TO LAUNCH KEFLEX IN JULY

April 24, 2006
A A

Advancis Pharmaceutical Corp. announced that the U.S. Food and Drug Administration has informed that its review of the supplemental New Drug Application for additional Keflex, or cephalexin capsules, USP, products is still ongoing.

Trading Markets (http://www.tradingmarkets.com/tm.site/news/BREAKING%20NEWS/229035/)